Letter: Tacrolimus May Be Hazardous in Decompensated Autoimmune Liver Disease With Hyperbilirubinaemia

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Tacrolimus May Be Hazardous in Decompensated Autoimmune Liver Disease With Hyperbilirubinemia-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Autoimmune Hepatitis-Drug-Induced Liver Injury Must Always Be Excluded

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Informed Consent May Be Hazardous to Health

Science
MultidisciplinaryPhilosophy of ScienceHistory
1979English

Letter: Autoimmune Hepatitis-Drug-Induced Liver Injury Must Always Be Excluded. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Warning: Corporations May Be Hazardous to Your Health

Health Affairs
MedicineHealth Policy
2010English

Treatment of Decompensated Alcoholic Liver Disease

International Journal of Hepatology
Hepatology
2011English

Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug Induced Liver Injury

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Autoimmune Liver Disease in Asian Children

Hepatology International
Hepatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy